You are here

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

 

Online download statistics by month:

Online download statistics by month: April 2021 to September 2024

AbstractFullPdf
Apr 2021744744164
May 2021531531133
Jun 2021247247117
Jul 202116916950
Aug 202117917736
Sep 202117617646
Oct 202118818864
Nov 202119419381
Dec 202116617055
Jan 202212513172
Feb 202210811383
Mar 202212612957
Apr 202214215474
May 202214515870
Jun 2022999947
Jul 2022979956
Aug 202214114646
Sep 202210610728
Oct 2022869961
Nov 2022767839
Dec 2022939337
Jan 2023828353
Feb 2023828465
Mar 202318919173
Apr 202313813945
May 2023929431
Jun 202311711843
Jul 202310710856
Aug 2023858641
Sep 202315715722
Oct 202318118131
Nov 202330030250
Dec 202313513526
Jan 20249810434
Feb 2024828536
Mar 2024919170
Apr 202412812856
May 202413513629
Jun 2024939643
Jul 2024889341
Aug 20247369119
Sep 2024808347
Total647165642427